(Q41234478)

English

Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial

scientific article published on 10 March 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 September 2017

Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial (English)

1 reference

Europe PubMed Central

28 September 2017

0 references

multicenter clinical trial

0 references

type 2 diabetes

0 references

0 references

1

object named as

Faiez Zannad

1 reference

Europe PubMed Central

28 September 2017

Christopher P Cannon

2

object named as

Christopher P Cannon

1 reference

Europe PubMed Central

28 September 2017

EXAMINE Investigators

13

object named as

EXAMINE Investigators

1 reference

Europe PubMed Central

28 September 2017

7

object named as

Penny R Fleck

1 reference

Europe PubMed Central

28 September 2017

9

object named as

Stuart Kupfer

1 reference

Europe PubMed Central

28 September 2017

author name string

William C Cushman

3

1 reference

Europe PubMed Central

28 September 2017

George L Bakris

4

1 reference

Europe PubMed Central

28 September 2017

Venu Menon

5

1 reference

Europe PubMed Central

28 September 2017

Alfonso T Perez

6

1 reference

Europe PubMed Central

28 September 2017

Cyrus R Mehta

8

1 reference

Europe PubMed Central

28 September 2017

Craig Wilson

10

1 reference

Europe PubMed Central

28 September 2017

Hung Lam

11

1 reference

Europe PubMed Central

28 September 2017

William B White

12

1 reference

Europe PubMed Central

28 September 2017

language of work or name

0 references

publication date

10 March 2015

1 reference

Europe PubMed Central

28 September 2017

1 reference

Europe PubMed Central

28 September 2017

385

1 reference

Europe PubMed Central

28 September 2017

9982

1 reference

Europe PubMed Central

28 September 2017

2067-2076

1 reference

Europe PubMed Central

28 September 2017

Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of diabetes in congestive heart failure: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of heart failure in patients with recent-onset type 2 diabetes: population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of readmission among elderly survivors of admission with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Does cardiovascular phenotype explain the association between diabetes and incident heart failure? The Strong Heart Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between glycated haemoglobin and the risk of congestive heart failure in diabetes mellitus: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Should antidiabetic treatment of type 2 diabetes in patients with heart failure differ from that in patients without?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: systematic review of observational studies involving 34,000 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Metformin use and mortality in ambulatory patients with diabetes and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Incretins as a novel therapeutic strategy in patients with diabetes and heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Dipeptidyl-peptidase IV inhibition improves pathophysiology of heart failure and increases survival rate in pressure-overloaded mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Dipeptidyl peptidase-4 modulates left ventricular dysfunction in chronic heart failure via angiogenesis-dependent and -independent actions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating dipeptidyl peptidase IV activity correlates with cardiac dysfunction in human and experimental heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Des-serine-proline brain natriuretic peptide 3-32 in cardiorenal regulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Dipeptidyl peptidase-4 inhibitors and heart failure: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes: meta-analysis of randomized clinical trials with 55,141 participants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacology of dipeptidyl peptidase-4 inhibitors: similarities and differences.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycaemia and heart failure in diabetes types 1 and 2

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2962225-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(14)62225-X

1 reference

Europe PubMed Central

28 September 2017

1 reference

Europe PubMed Central

28 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41234478&oldid=2113649634"